Authors: Kratz, F Drevs, J Bing, G Stockmar, C Scheuermann, K Lazar, P Unger, C

Citation: F. Kratz et al., Development and in vitro efficacy of novel MMP2 and MMP9 specific doxorubicin albumin conjugates, BIOORG MED, 11(15), 2001, pp. 2001-2006

Authors: Kratz, F Muller-Driver, R Hofmann, I Drevs, J Unger, C

Citation: F. Kratz et al., A novel macromolecular prodrug concept exploiting endogenous serum albuminas a drug carrier for cancer chemotherapy, J MED CHEM, 43(7), 2000, pp. 1253-1256

Authors: Wood, JM Bold, G Buchdunger, E Cozens, R Ferrari, S Frei, J Hofmann, F Mestan, J Mett, H O'Reilly, T Persohn, E Rosel, J Schnell, C Stover, D Theuer, A Towbin, H Wenger, F Woods-Cook, K Menrad, A Siemeister, G Schirner, M Thierauch, KH Schneider, MR Drevs, J Martiny-Baron, G Totzke, F Marme, D

Citation: Jm. Wood et al., PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration, CANCER RES, 60(8), 2000, pp. 2178-2189

Authors: Drevs, J Hofmann, I Hugenschmidt, H Wittig, C Madjar, H Muller, M Wood, J Martiny-Baron, G Unger, C Marme, D

Citation: J. Drevs et al., Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and flood flow in a murine renal cell carcinoma model, CANCER RES, 60(17), 2000, pp. 4819-4824

Authors: Drevs, J Droll, A Mross, K Unger, C

Citation: J. Drevs et al., Angiogenesis inhibition: Drugs in clinical trials, ONKOLOGIE, 22(4), 1999, pp. 282-290

Authors: Drevs, J Unger, C

Citation: J. Drevs et C. Unger, Influence of enzyme preparations on coagulation and metastasis of malignant tumors, INTERNIST, 40(7), 1999, pp. 806-807